| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |